Nike Q4: Quality First, Margins Recover Ahead of Revenue

Overview

This report is Bernstein’s earnings review of Nike’s Q4 results and management commentary. The core view is that Nike remains in a revenue-pressure phase in the short term, but the company is actively choosing “quality over quantity”: reducing low-quality sales, controlling promotions, increasing full-price sales, and improving channel inventory. The report maintains an Outperform rating, but cuts its FY28 EPS forecast from $2.91 to $2.67 and accordingly lowers the target price to $72.

Core views

The report believes Nike’s recovery has not been delayed, but will be more weighted toward 2H FY27. Revenue may still decline low- to mid-single digits over the next two quarters, with China and Lifestyle/Jordan Streetwear remaining drags; however, gross margin, SG&A, and cost efficiency are likely to improve ahead of revenue. Management is more optimistic on calendar 2027, with the Win Now transformation program expected to end by late 2026, and the Spring 2027 product cycle under the Sport Offense framework becoming an important support for medium-term growth and margin recovery.

Analysis framework

Using Q4 actual results, management guidance, regional and channel breakdowns, category trends, gross margin and expense bridges, tariff impacts, and the valuation model as the main framework, the report assesses the sustainability of Nike’s near-term revenue quality improvement and medium-term margin recovery. Valuation derives the target price by applying 27x P/E to the FY2028 EPS forecast.

Methodology notes

• earnings reviewquarterly results and management guidance cross-check

  Compare Q4 revenue, gross margin, SG&A, EPS, and regional/channel performance against company guidance and market expectations.

  The report emphasizes that Q4 sales came in slightly ahead of guidance and EPS guidance was not cut again, indicating the business is starting to stabilize, though revenue recovery likely has to wait until 2H FY27.

• valuation methodP/E multiple valuation

  Apply a 27x P/E multiple to the FY2028 EPS forecast of $2.67 to derive the $72 target price.

  The target price cut mainly comes from the lower FY28 EPS forecast, while the valuation multiple remains unchanged at 27x.

• margin analysisoperating margin bridge

  Break down the impact of tariffs, full-price sales, discounting, inventory management, supply chain efficiency, and cost cuts on FY27 margins.

  The report expects FY27 operating margin to be roughly flat, with tariffs becoming a headwind again but offset by improved full-price selling and cost efficiency.

• operating quality analysisregional, channel, and category breakdown

  Track North America, Europe, APLA, China, as well as Wholesale, DTC, Performance, Lifestyle, and other dimensions.

  North America and Performance are the recovery highlights, while China and Lifestyle remain drags; this breakdown supports the view of a “quality-first” recovery path.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Nike Inc (NKE.US)

  core research coverage target, U.S.-listed common equity

  Strengths

  The brand still has global influence; North America is leading the recovery; the Performance category and Running are strong; full-price selling, inventory management, supply chain efficiency, and cost cuts should help margins recover ahead of revenue; the Spring 2027 product cycle and Sport Offense organizational framework provide medium-term growth support.

  Weaknesses

  Short-term revenue will still decline; China constant-currency sales fell 17%; Lifestyle and Jordan Streetwear account for about half of revenue and are still expected to post negative growth in FY27; DTC is weaker than Wholesale.

  Comparison

  Q4 sales of -1% were better than guidance of -2% to -4%; Wholesale outperformed DTC; North America and Performance were clearly stronger than China and Lifestyle.

  Risks

  China recovery slower than expected, slower growth in the sportswear industry, share loss due to competition, tariffs and cost pressure, and concentrated supplier disruption risk.

Key data

• ratingOutperformBernstein maintains its outperform rating, with the rating framework based on 12-month relative performance.
• target price72.00 USD, previously 80.00 USDThe target price cut stems from a lower FY28 EPS forecast, while the valuation multiple remains at 27x.
• FY28 EPS forecast2.67 USD, previously 2.91 USDForward earnings forecast used for target price valuation.
• Q4 sales growth-1% YoYBetter than company guidance of -2% to -4%, though May trends slowed somewhat.
• channel performanceWholesale -1% cc; DTC -9% ccWholesale outperformed DTC, with North America wholesale delivering double-digit growth.
• China sales-17% ccChina remains a drag on overall growth, and management is still resetting competitive positioning and brand perception.
• Performance categorymid-single-digit growthRunning posted double-digit growth for the fifth consecutive quarter, while Football, Training, ACG, and Basketball also improved or are about to scale up.
• Lifestyle and Jordan StreetwearCombined about 50% of revenue, expected to remain negative growth in FY27Management expects trends to improve in 2H calendar 2027 with new product launches.
• underlying gross margin40.2%, flat YoYRemained stable despite tariff headwinds, benefiting from better full-price selling.
• IEEPA tariff refund impact+900 bps margin; +0.52 USD EPS; total USD 986 millionAs of Q4, USD 300 million had been received, with the remainder booked in accounts receivable.
• H1 FY27 revenue guidancelow- to mid-single-digit declineMainly driven by reduced low-quality sell-in, a high Q2 base, and a weak consumer environment.
• FY27 margin viewoperating margin roughly flatReported FY26 operating margin was 8.3%; FY27 tariff headwinds are offset by full-price selling and cost cuts.
• investor dayNovember 16-17, 2026Will disclose guidance for 2H FY27, medium-term targets, and the innovation product pipeline.

Impact & implications

For investors, the report conveys a combination of “improving fundamental quality but limited near-term upside momentum in the stock.” Stable EPS guidance eases concerns about another downward revision, but revenue will remain under pressure for two more quarters, implying that earnings growth and valuation re-rating are more likely to wait until 2H FY27. If the investor day confirms the medium-term algorithm, innovation pipeline, and margin path, it could become a catalyst for stock re-rating.

Risks

• Overall global Sportswear growth is slower than expected.
• Nike’s recovery in China is slower than expected and it continues to lose market share.
• Inflation, freight, channel costs, or other operating expense pressures erode margins.
• Competitors take share in key markets such as North America.
• Supplier concentration is relatively high, creating supply disruption risk.
• An uncertain demand environment could delay the revenue and margin inflection in 2H FY27.
• Tariff assumptions may change, with tariffs again becoming a margin headwind in FY27.

What to watch

• Disclosure at the investor day on November 16-17, 2026 regarding guidance for 2H FY27, medium-term targets, and the innovation pipeline.
• Whether the revenue decline over the next two quarters is kept within the low- to mid-single-digit range.
• Whether gross margin turns positive in Q1 FY27 as guided by management, and whether overall margin turns positive in Q2 FY27.
• Whether post-reset store sales and sell-through in China continue to improve.
• Whether new product launches in Lifestyle and Jordan Streetwear in 2H calendar 2027 drive trend improvement.
• Execution of the new product pipeline in Performance, Running, Basketball, Training, and Sportswear.
• The actual impact of tariffs, discounting, and inventory management on FY27 operating margin.